The seed follow-on round was backed by a consortium including AlbionVC, Delin Ventures, and Playfair Capital.
"Our technology can support healthcare providers in finding appropriate patients to participate in medical research including large scale patient registries which usually demands laborious, manual processes on top of their already complex and heavy workloads."
The Series C round was led by Kinnevik with participation from new and existing investors to support international expansion.
"This has been an exceptional year of growth for HungryPanda. We can launch in new cities in just two weeks and have established ourselves as the market leader due to our laser focus on developing the best service for our customers and providing high-quality execution."
Seedcamp led the financing round to help fund the digital health startup's public rollout.
"While working as a doctor, I saw firsthand the devastating complications of type 2 diabetes – from strokes to heart attacks to blindness. For the majority of patients, pills are not solving the problem. We now have strong clinical evidence that remission can be the goal for most patients. Sadly, with the NHS at a breaking point, it is not in a place to deliver intensive remission programs to the 4.2 million type 2 diabetics in the UK."